Inhibitor of Interferon type I (IFN-I) is capable of inhibiting the inflammatory response in those autoimmune diseases in which this cytokine is involved, called interferonopathies, such as systemic lupus erythematosus and Aicardi-Goutières syndrome.
A new immunotherapy strategy based on the administration of ADCs or CAR-T cells derived from a monoclonal antibody specific for the pre-TCR receptor, which impairs LIC activity and tumor progression, has been developed and validated in a preclinical human T-ALL xenotransplantation model in mice.
Monitor and reduce pathological tremors in users through a neuroprosthetic system able to stimulate patient´s affected pathways.
Highly efficient nickel catalyst for the deuteration of silanes and boranes, offering high conversions, mild reaction conditions, and broad versatility, covering primary, secondary, and tertiary silanes, as well as various types of boranes.
Novel compounds based on a repurposed drug to combat gram (+) bacterial infections.
New family of molecules derived from Isoquercetin for the treatment and/or prevention of inflammatory and degenerative eye diseases.
Novel Hydrogel with optimized mechanical and structural properties to resemble artificial lymph nodes and improve primary human CAR-T cell manufacture.
New synthesis method to produce ε -Fe2O3 nanoparticles for magnetic memories or wireless communication devices
New device for vacuum sublimation. The sublimator allows the deposition of materials directly onto the desired substrate without using an intermediate Surface or solvents, or other intermediate substances for the deposition.
New disposable electrochemical sensor for the on-site detection of water pollutants. It is a sample-to-result device that does not require manual sample pre-treatment.